Video HIT in Sudden Sensorineural Hearing Loss
NCT04224909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2020-01-13
Summary
The function of the vestibular system among patients with Sudden Sensori Neural Hearing Loss will be evaluted using the video Head Impulse Test
Conditions
- Sudden Sensorineural Hearing Loss
Interventions
- DIAGNOSTIC_TEST
-
Video Head Impulse Test
Diagnosis of dysfunction of the semicircular canals using the vHIT
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2021-01-31
- Completion
- 2021-01-31
- FDA Device
- Yes
More Related Trials
-
Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss
NCT06878599 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Hydrogen-oxygen Gas Mixture Inhalation in Patients With Sudden Sensorineural Hearing Loss
NCT04881435 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
NCT06278129 ·Status: RECRUITING
-
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
NCT04686695 ·Status: COMPLETED ·Phase: NA
-
Blood Markers in Adult Patients With Sudden Sensorineural Hearing Loss (SSNHL)
NCT03919474 ·Status: COMPLETED
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT06544590 ·Status: COMPLETED
-
Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
NCT00802425 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic of Various Ototoxicity Induced by Cancer Treatment
NCT06490029 ·Status: RECRUITING
-
The Effect of Patient's Position After Intra-tympanic Injection
NCT04384640 ·Status: UNKNOWN
-
FX-322 in Adults With Severe Sensorineural Hearing Loss
NCT04629664 ·Status: COMPLETED ·Phase: PHASE1
-
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
NCT04601909 ·Status: COMPLETED ·Phase: PHASE1
-
CNS Infections Effect on the Inner Ear
NCT03715569 ·Status: UNKNOWN
-
Phase I Clinical Study of HY01 in Patients
NCT04961099 ·Status: UNKNOWN ·Phase: PHASE1
-
Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss
NCT05112354 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy
NCT07282028 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Influence of Covid-19 on the Audio-vestibular System
NCT04709146 ·Status: UNKNOWN ·Phase: NA
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT05328895 ·Status: COMPLETED ·Phase: NA
-
Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids
NCT03974867 ·Status: UNKNOWN ·Phase: NA
-
Ischemia- Modified Albumin Levels in the Sudden Hearing Loss
NCT03706183 ·Status: UNKNOWN
-
Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL
NCT03331627 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Steroid Therapy in Vestibular Neuritis
NCT02098330 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
NCT06249919 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
NCT02809118 ·Status: TERMINATED ·Phase: PHASE3
-
The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss
NCT05403229 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
NCT01621256 ·Status: COMPLETED ·Phase: PHASE1/PHASE2